Bladder Cancer - Neoadjuvant Therapy with Cisplatin and Gemcitabine

被引:0
|
作者
Schmid, Sebastian C. [1 ]
Gschwend, Juergen E. [1 ]
Retz, Margitta [1 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Urol Klin & Poliklin, D-80290 Munich, Germany
关键词
CHEMOTHERAPY; CYSTECTOMY;
D O I
10.1055/s-0033-1356861
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:340 / 342
页数:5
相关论文
共 50 条
  • [31] Gemcitabine and cisplatin in locally advanced and/or metastatic bladder cancer
    von der Maase, H.
    EUROPEAN JOURNAL OF CANCER, 2000, 36 : S13 - S16
  • [32] Gemcitabine and cisplatin for advanced, metastatic bladder cancer -: In reply
    von der Maase, H
    Hayden, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) : 1229 - 1231
  • [33] Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer
    Golcher, Henriette
    Brunner, Thomas B.
    Witzigmann, Helmut
    Marti, Lukas
    Bechstein, Wolf-Otto
    Bruns, Christiane
    Jungnickel, Henry
    Schreiber, Stefan
    Grabenbauer, Gerhard G.
    Meyer, Thomas
    Merkel, Susanne
    Fietkau, Rainer
    Hohenberger, Werner
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (01) : 7 - 16
  • [34] Comparative effectiveness of gemcitabine plus cisplatin (GC) versus methotrexate, vinblastine, doxorubicin, plus cisplatin (MVAC) as neoadjuvant therapy for muscle-invasive bladder cancer (MIBC).
    Galsky, Matt D.
    Harshman, Lauren Christine
    Crabb, Simon J.
    Wong, Yu-Ning
    Yu, Evan Y.
    Chowdhury, Simon
    Powles, Thomas
    Pal, Sumanta Kumar
    Moshier, Erin L.
    Ladoire, Sylvain
    Hussain, Syed A.
    Agarwal, Neeraj
    Vaishampayan, Ulka N.
    Recine, Federica
    Berthold, Dominik
    Necchi, Andrea
    Theodore, Christine
    Milowsky, Matthew I.
    Bellmunt, Joaquim
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] Curative Effect and Survival Assessment Comparing Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin and Cisplatin as Neoadjuvant Therapy for Bladder Cancer: A Systematic Review and Meta-Analysis
    Wu, Tiange
    Wu, Yuqing
    Chen, Shuqiu
    Wu, Jianping
    Zhu, Weidong
    Liu, Hui
    Chen, Ming
    Xu, Bin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [36] Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer
    Sarah M. H. Einerhand
    Anna J. Black
    Homayoun Zargar
    Adrian S. Fairey
    Colin P. Dinney
    Maria C. Mir
    Laura-Maria Krabbe
    Michael S. Cookson
    Niels-Erik Jacobson
    Jeffrey S. Montgomery
    Nikhil Vasdev
    Evan Y. Yu
    Evanguelos Xylinas
    Wassim Kassouf
    Marc A. Dall’Era
    Srikala S. Sridhar
    Jonathan S. McGrath
    Jonathan Aning
    Shahrokh F. Shariat
    Jonathan L. Wright
    Andrew C. Thorpe
    Todd M. Morgan
    Jeff M. Holzbeierlein
    Trinity J. Bivalacqua
    Scott North
    Daniel A. Barocas
    Yair Lotan
    Petros Grivas
    Jorge A. Garcia
    Andrew J. Stephenson
    Jay B. Shah
    Siamak Daneshmand
    Kamran Zargar-Shoshtari
    Philippe E. Spiess
    Bas W. G. van Rhijn
    Peter C. Black
    Laura S. Mertens
    World Journal of Urology, 2022, 40 : 2707 - 2715
  • [37] Muscle invasive bladder cancer treated with gemcitabine plus cisplatin as neoadjuvant chemotherapy during the second trimester of pregnancy
    Sasaki, Takeshi
    Ryota, Ikadai
    Ishiyama, Akinobu
    Takakura, Sho
    Kato, Momoko
    Owa, Shunsuke
    Nishikawa, Taketomo
    Higashi, Shinichiro
    Nishikawa, Kouhei
    Inoue, Takahiro
    IJU CASE REPORTS, 2025, 8 (02) : 138 - 141
  • [38] Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer
    Lee, Franklin C.
    Harris, William
    Cheng, Heather H.
    Shenoi, Jaideep
    Zhao, Song
    Wang, Junfeng
    Champion, Thomas
    Izard, Jason
    Gore, John L.
    Porter, Michael
    Yu, Evan Y.
    Wright, Jonathan L.
    ADVANCES IN UROLOGY, 2013, 2013
  • [39] Comparative analysis of three vs. four cycles of neoadjuvant gemcitabine and cisplatin for muscle invasive bladder cancer
    Aydin, Ahmet Murat
    Cheriyan, Salim K.
    Reich, Richard
    Hajiran, Ali
    Peyton, Charles C.
    Zemp, Logan
    Yu, Alice
    Li, Roger
    Poch, Michael A.
    Spiess, Philippe E.
    Jain, Rohit
    Zhang, Jingsong
    Sexton, Wade J.
    Gilbert, Scott M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (10) : 453.e19 - 453.e26
  • [40] DOES NEOADJUVANT CHEMOTHERAPY WITH GEMCITABINE AND CISPLATIN IN BLADDER CANCER INCREASE THE COMPLICATIONS AT RADICAL CYSTECTOMY IN HIGH AGE PATIENTS?
    Fukumoto, Keishiro
    Kikuchi, Eiji
    Shirotake, Suguru
    Hakozaki, Kyohei
    Miyazaki, Yasumasa
    Maeda, Takahiro
    Kaneko, Gou
    Yoshimine, Shunsuke
    Tanaka, Nobuhiro
    Kanai, Kunimitsu
    Oyama, Masafumi
    Nakajima, Yosuke
    Momma, Tetsuo
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1041 - E1042